MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. - Wikidata - wikimedia - TriplyDB

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

http://www.wikidata.org/entity/Q39528026

about

A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.Clinical significance of E2F1 protein expression in non-small cell lung cancer Modulation of cancer traits by tumor suppressor microRNAs.MiR-106a is an independent prognostic marker in patients with glioblastoma.E2F1-miR-20a-5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiation Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.High-throughput microRNA profiling of pediatric high-grade gliomas.MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.Diagnostic and prognostic value of miR-106a in colorectal cancer.MicroRNAs in neural cell development and brain diseases.Emerging roles of microRNA in modulating cell-death processes in malignant glioma.The miRNA network: micro-regulator of cell signaling in cancer.MicroRNAs and cell cycle of malignant glioma.Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.E2F1: a promising regulator in ovarian carcinoma.Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells.Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.The miR-106a~363Xpcl1 miRNA cluster induces murine T cell lymphoma despite transcriptional activation of the p27Kip1 cell cycle inhibitor.An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes.CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma.microRNA‑372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1.An ultrasensitive SERS sensor for simultaneous detection of multiple cancer-related miRNAs.mir-300 promotes self-renewal and inhibits the differentiation of glioma stem-like cells.Upregulated miR-106a plays an oncogenic role in pancreatic cancer.MicroRNA-106a inhibits cell proliferation and induces apoptosis in colorectal cancer cells.

P2860

Q24633772-0E98E8F1-8BED-4428-BEBA-038B173FFC60 Q28547067-C7866D7E-12F1-4984-837B-26D985965892 Q34073992-4A9F6FB1-CB71-47B6-B0C0-D679DDFF955F Q34325808-8FFA0B95-E599-40C6-8719-F66FDA83E680 Q34409620-33CF5C95-8C39-40EB-914A-8E368D538F44 Q34980918-A1C1955B-05D1-4028-9F5C-891FF0787B1D Q35017237-8FAE7760-7E96-43DA-B6B8-939B50A945F8 Q35741033-8AF56C3B-BAA0-448B-B71A-CCA0ADD1F8B3 Q35788900-6DB66EFF-E8AD-412F-910A-C13E8FCAEE16 Q36245788-7592CF41-E135-4BE3-9BF3-B26AB0CEE214 Q36375834-E4DCE43B-19E9-4136-9FC0-3A1139AAA693 Q36444495-4C3FEA8B-E517-4AF2-BD43-27F05D75CBD9 Q36590130-D2C8974B-A977-4ACB-8D2C-DD8616FCFCE6 Q36865988-6792FF22-5095-4C2A-A06C-BD02FF9CECB0 Q36990698-EA8C7773-641A-4A92-84A6-2639E130D370 Q37335617-78A3CDB0-F4EE-41B4-BF3B-A521AD507194 Q37492187-B5D9CAF4-596D-4F11-950A-10BD5A30934D Q37699427-C8E68734-0A8D-40F1-BDB0-B178F2022324 Q37706295-21F62DDE-4692-4BE6-94FE-B59875693699 Q37974078-0A5D4B56-19F7-4C8A-A4DE-8A046B498E3B Q38127635-B2D1215F-8AB7-4CC5-BCDD-FB67DC774E71 Q38243969-0339B92F-2A4E-4259-B7D1-A628B3C9B371 Q38497875-5F748E5A-81EB-4C1F-90FB-701E64C39B50 Q38621047-83F2BF81-FB17-4CF4-8259-6EE735495EB7 Q38691452-C650452C-8989-4C4A-AE2F-6EDFEFB040F9 Q38800435-78BA4E4F-1818-4EAD-A92E-8F7AE7CB689A Q39037653-7D9A0310-526B-4BAF-B648-776B4E1FD302 Q39096209-3540AAE7-5492-40E7-A3A8-72430DC659E0 Q39124132-8FD475B4-7E2B-4A76-8A9A-CEE486FBDA74 Q40612887-BC9F0036-429A-42F4-B6FE-0E85046E7D86 Q41163628-993F6C3B-6BE9-4D53-B1A8-EFABD0ED3512 Q41208796-7DFA1FFC-AF8A-4F67-959F-9B395531A09A Q41612354-63ECD8DE-8C07-4024-9755-56E1313ECFAE Q42013246-73A03655-C5A9-4691-BA50-152F6CD2F8C4 Q48400320-C083B139-A7A4-4091-8E10-52CF5EC7185B Q49479439-7ECE38CC-CBAA-44EF-9A1C-EC150C52D931 Q51143054-26E05C53-2750-4A4D-8856-BBDC838EA013 Q53070197-138C4500-9C39-46D4-B924-B35918E53BF9 Q53071807-0692AC33-06DA-4AD2-95FA-2D22566F68E4 Q55184609-BBD58022-515F-466A-9FA1-AEA44B783BFC

P2860

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

http://www.wikidata.org/entity/Q39528026

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@en

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@nl

type

label

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@en

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@nl

prefLabel

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@en

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

@nl

P1433

Q39528026-B9C1F9A4-2E6A-4FEC-8A7A-18139B16DB3E

P1476

Q39528026-3964DAD7-A3DF-4539-B723-E2568C80E511

P2093

Q39528026-071F3B47-FD31-493D-B1E8-8F02B84C034A

Q39528026-34AA1E54-4542-49B3-BF07-D224FB98F1B1

Q39528026-350BF43B-DCA6-4861-B3C6-42BAF0E66B85

Q39528026-47504B49-567E-4017-AB6A-40223C35A8FF

Q39528026-53E52F47-53ED-4E70-9843-507D4E9C150D

Q39528026-6CD624B8-B641-4BC3-8342-DEDD46844D1E

Q39528026-85033A79-5BA6-40B4-A1EE-3C2AAF6521EC

Q39528026-B7D05368-DCF1-47FE-82EB-3302DF571FFF

Q39528026-CA6EA5A0-6366-4427-A566-F2288FB38896

Q39528026-EEFBE63A-8E23-4AC5-B137-5C5AC2395BD4

P2860

Q39528026-21928265-8D20-44EF-96D2-CA7D3FBA1FB1

Q39528026-35544A66-DEC3-4763-82D8-1BEE9351F784

Q39528026-3FD5473B-97E2-46A8-BC48-AABEA7579CDA

Q39528026-40C7353E-AD04-4F54-B71A-C8C6F07F048F

Q39528026-411EB9CC-4A04-4E3D-893F-C79D05459657

Q39528026-443A1C8B-8D98-4A78-8300-28EF48851989

Q39528026-4C4A0D8F-ABD1-4879-810B-F2960FEC17A6

Q39528026-4E670FBB-2DF8-42CF-A95C-44A344A55A90

Q39528026-5497DAA6-7E14-453E-9258-02761E502CD3

Q39528026-5A2D3512-409B-4CC4-AAA1-314892FBDDDC

P2888

Q39528026-D0EE0B92-5EB7-431C-A9A1-C3D67CB3455B

P304

Q39528026-948BC5E6-4BAE-4E62-A574-406000FE5354

P31

Q39528026-EDD7CFD8-561B-481A-8C77-C18641EA3710

P356

Q39528026-0655A437-59FE-46FF-8F1C-3D18EE1B9F3A

P433

Q39528026-181761FF-5E4C-43F9-BE82-837F1D88AD0D

P478

Q39528026-E1D3B5D4-08A1-419F-8D9E-959A76EE603B

P50

Q39528026-49C2E8FD-9B15-455E-9CE3-4918A6FFA468

P577

Q39528026-D9A18BBB-3DBE-401B-943A-B0570B8A6D9C

P698

Q39528026-5803A6BB-5A4C-4CC6-B0B1-F4DC460467BF

P356

S00109-011-0775-X

P1433

Journal of Molecular Medicine

P1476

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status

@en

P2093

Baofeng Yang

http://www.w3.org/2001/XMLSchema#string

Changbin Shi

http://www.w3.org/2001/XMLSchema#string

Chen Shi

http://www.w3.org/2001/XMLSchema#string

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Hulun Li

http://www.w3.org/2001/XMLSchema#string

Jing Ai

http://www.w3.org/2001/XMLSchema#string

Lihua Sun

http://www.w3.org/2001/XMLSchema#string

Ruyou Zhang

http://www.w3.org/2001/XMLSchema#string

Shiguang Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Chen

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

E2F1 in melanoma progression and metastasis

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

Malignant gliomas in adults

Advances in the genetics of glioblastoma: are we reaching critical mass?

P2888

s00109-011-0775-x

P304

1037-1050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-011-0775-X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Nikolai G. Rainov

P577

2011-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21656380

http://www.w3.org/2001/XMLSchema#string